amphiregulin targeting human mAbs (Cytodesign)

N/A

Report date: 2025/03/17 20:00:36

Base Information

Drug Nameamphiregulin targeting human mAbs (Cytodesign)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment

Mechanisms of ActionAmphiregulin inhibitors

TargetsAmphiregulin

Therapy Area/IndicationsPsoriasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCytodesign Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCytodesign Inc

Active IndicationsN/A

Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A